Month: January 2020
-
Biotech Options Enzyme Inhibitors for Lung Cancer
A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer.
-
Artificial Pancreas System Cleared by FDA
A system for automatically measuring blood glucose levels and dispensing insulin for people with type 1 diabetes is authorized by the Food and Drug Administration.